Cardiome Pharma Corp (NASDAQ:CRME)

9.57
Delayed Data
As of May 29
 +0.07 / +0.74%
Today’s Change
5.84
Today|||52-Week Range
11.31
+3.46%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 12.50, with a high estimate of 16.00 and a low estimate of 5.00. The median estimate represents a +30.62% increase from the last price of 9.57.

Chart unavailable

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.16
Sales
$7.6M
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 32.61%
 
 
 
 
 
 
Growthannually 66.96%
 
 
 
 
 
 

Sales

Growthquarterly 38.91%
 
 
 
 
 
 
Growthannually 8.72%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account